Trial Profile
Safety and pharmacokinetic study of sacubitril/valsartan (LCZ696) and atorvastatin in healthy Chinese male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Atorvastatin
- Indications Essential hypertension; Heart failure; Hypertension
- Focus Adverse reactions; Pharmacokinetics
- 10 Jun 2016 New trial record
- 31 May 2016 Results published in the European Journal of Drug Metabolism and Pharmacokinetics